Approach to metabolic acidosis: Clinical sciences

1,182views

test

00:00 / 00:00

Approach to metabolic acidosis: Clinical sciences

Pediatrics

Pediatrics

Approach to acid-base disorders: Clinical sciences
Approach to metabolic acidosis: Clinical sciences
Approach to metabolic alkalosis: Clinical sciences
Approach to respiratory acidosis: Clinical sciences
Approach to respiratory alkalosis: Clinical sciences
Approach to hypernatremia (pediatrics): Clinical sciences
Approach to hypocalcemia (pediatrics): Clinical sciences
Approach to hypoglycemia (pediatrics): Clinical sciences
Approach to hyponatremia (pediatrics): Clinical sciences
Adrenal insufficiency: Clinical sciences
Syndrome of inappropriate antidiuretic hormone secretion: Clinical sciences
Adnexal torsion: Clinical sciences
Appendicitis: Clinical sciences
Approach to abdominal wall and groin masses: Clinical sciences
Approach to dysmenorrhea: Clinical sciences
Cholecystitis: Clinical sciences
Ectopic pregnancy: Clinical sciences
Henoch-Schonlein purpura: Clinical sciences
Inflammatory bowel disease (Crohn disease): Clinical sciences
Inflammatory bowel disease (ulcerative colitis): Clinical sciences
Intussusception: Clinical sciences
Irritable bowel syndrome: Clinical sciences
Pelvic inflammatory disease: Clinical sciences
Testicular torsion (pediatrics): Clinical sciences
Urinary tract infection (pediatrics): Clinical sciences
Approach to anemia (destruction and sequestration): Clinical sciences
Approach to anemia (underproduction): Clinical sciences
Approach to anemia in the newborn and infant (destruction and blood loss): Clinical sciences
Approach to anemia in the newborn and infant (underproduction): Clinical sciences
Approach to leukemia: Clinical sciences
Iron deficiency and iron deficiency anemia (pediatrics): Clinical sciences
Sickle cell disease: Clinical sciences
Approach to bleeding disorders (platelet dysfunction): Clinical sciences
Approach to bleeding disorders (thrombocytopenia): Clinical sciences
Immune thrombocytopenia: Clinical sciences
Meningitis (pediatrics): Clinical sciences
Sepsis (pediatrics): Clinical sciences
Celiac disease: Clinical sciences
Asthma: Clinical sciences
Bronchiolitis: Clinical sciences
Congestive heart failure: Clinical sciences
COVID-19: Clinical sciences
Croup and epiglottitis: Clinical sciences
Cystic fibrosis and primary ciliary dyskinesia: Clinical sciences
Influenza: Clinical sciences
Pneumonia (pediatrics): Clinical sciences
Tuberculosis (pulmonary): Clinical sciences
Upper respiratory tract infections: Clinical sciences
Clostridioides difficile infection: Clinical sciences
Approach to a fever (over 2 months): Clinical sciences
Acute rheumatic fever and rheumatic heart disease: Clinical sciences
Osteomyelitis (pediatrics): Clinical sciences
Otitis media and externa (pediatrics): Clinical sciences
Pharyngitis, peritonsillar abscess, and retropharyngeal abscess (pediatrics): Clinical sciences
Septic arthritis and transient synovitis (pediatrics): Clinical sciences
Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical sciences
Tuberculosis (extrapulmonary and latent): Clinical sciences
Approach to bacterial causes of fever and rash (pediatrics): Clinical sciences
Acute group A streptococcal infections and sequelae (pediatrics): Clinical sciences
Approach to congenital infections: Clinical sciences
Juvenile idiopathic arthritis: Clinical sciences
Kawasaki disease: Clinical sciences
Lyme disease: Clinical sciences
Periorbital and orbital cellulitis (pediatrics): Clinical sciences
Toxic shock syndrome: Clinical sciences
Staphylococcal scalded skin syndrome and impetigo: Clinical sciences
Approach to a murmur (pediatrics): Clinical sciences
Approach to congenital heart diseases (acyanotic): Clinical sciences
Approach to congenital heart diseases (cyanotic): Clinical sciences
Hypertrophic cardiomyopathy: Clinical sciences
Approach to hepatic masses: Clinical sciences
Hepatitis A and E: Clinical sciences
Hepatitis B: Clinical sciences
Hepatitis C: Clinical sciences
Approach to a limp (pediatrics): Clinical sciences
Approach to a suspected bone tumor (pediatrics): Clinical sciences
Developmental dysplasia of the hip: Clinical sciences
Legg-Calve-Perthes disease and slipped capital femoral epiphysis: Clinical sciences
Approach to peripheral lymphadenopathy (pediatrics): Clinical sciences
Approach to a red eye: Clinical sciences
Approach to vomiting (newborn and infant): Clinical sciences
Acetaminophen (Paracetamol) toxicity: Clinical sciences
Approach to recreational substance exposure (pediatrics): Clinical sciences
Diabetes mellitus (pediatrics): Clinical sciences
Large bowel obstruction: Clinical sciences
Pyloric stenosis: Clinical sciences
Small bowel obstruction: Clinical sciences
Approach to a fever (0-60 days): Clinical sciences
Approach to jaundice (newborn and infant): Clinical sciences
Non-accidental trauma and neglect (pediatrics): Clinical sciences
Necrotizing enterocolitis: Clinical sciences
Neonatal respiratory distress syndrome: Clinical sciences
Approach to respiratory distress (newborn): Clinical sciences
Approach to cyanosis (newborn): Clinical sciences
Approach to shock (pediatrics): Clinical sciences
Approach to lower airway obstruction (pediatrics): Clinical sciences
Approach to upper airway obstruction (pediatrics): Clinical sciences
Anaphylaxis: Clinical sciences
Foreign body aspiration and ingestion (pediatrics): Clinical sciences
Approach to a first unprovoked seizure (pediatrics): Clinical sciences
Febrile seizure (pediatrics): Clinical sciences
Approach to bradycardia: Clinical sciences
Approach to tachycardia: Clinical sciences
Brief, resolved, unexplained event (BRUE): Clinical sciences
Approach to hematochezia (pediatrics): Clinical sciences
Burns: Clinical sciences
Neurogenic shock: Clinical sciences
Approach to delayed puberty: Clinical sciences
Approach to feeding and eating disorders: Clinical sciences
Approach to neurodevelopmental disorders: Clinical sciences
Approach to precocious puberty: Clinical sciences
Approach to short stature: Clinical sciences
Autism spectrum disorder: Clinical sciences
Approach to a child with Down syndrome (trisomy 21): Clinical sciences
Dyslipidemia: Clinical sciences
Essential hypertension: Clinical sciences
Developmental milestones (newborn and infant): Clinical sciences
Developmental milestones (toddler): Clinical sciences
Developmental milestones (childhood): Clinical sciences
Approach to a rash in the well newborn and infant: Clinical sciences
Immunizations (pediatrics): Clinical sciences
Well-child visit (adolescent): Clinical sciences
Well-child visit (newborn and infant): Clinical sciences
Well-child visit (toddler and child): Clinical sciences
Well-patient care (GYN): Clinical sciences
Sports physical (pediatrics): Clinical sciences
Antidiuretic hormone
Body fluid compartments
Movement of water between body compartments
Sodium homeostasis
Acid-base disturbances: Pathology review
Diabetes insipidus and SIADH: Pathology review
Electrolyte disturbances: Pathology review
Renal failure: Pathology review
Acyanotic congenital heart defects: Pathology review
Adrenal masses: Pathology review
Bacterial and viral skin infections: Pathology review
Bone tumors: Pathology review
Coagulation disorders: Pathology review
Congenital neurological disorders: Pathology review
Cyanotic congenital heart defects: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Eye conditions: Inflammation, infections and trauma: Pathology review
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Headaches: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Leukemias: Pathology review
Lymphomas: Pathology review
Macrocytic anemia: Pathology review
Microcytic anemia: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Nasal, oral and pharyngeal diseases: Pathology review
Nephritic syndromes: Pathology review
Nephrotic syndromes: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Pediatric brain tumors: Pathology review
Pediatric musculoskeletal disorders: Pathology review
Platelet disorders: Pathology review
Renal and urinary tract masses: Pathology review
Seizures: Pathology review
Viral exanthems of childhood: Pathology review
Adrenal insufficiency: Pathology review
Central nervous system infections: Pathology review
Childhood and early-onset psychological disorders: Pathology review
Congenital gastrointestinal disorders: Pathology review
Diabetes mellitus: Pathology review
Environmental and chemical toxicities: Pathology review
Gastrointestinal bleeding: Pathology review
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Inflammatory bowel disease: Pathology review
Medication overdoses and toxicities: Pathology review
Obstructive lung diseases: Pathology review
Pneumonia: Pathology review
Psychiatric emergencies: Pathology review
Shock: Pathology review
Supraventricular arrhythmias: Pathology review
Traumatic brain injury: Pathology review
Ventricular arrhythmias: Pathology review
Congenital TORCH infections: Pathology review
Jaundice: Pathology review
Respiratory distress syndrome: Pathology review
Autosomal trisomies: Pathology review
Cystic fibrosis: Pathology review
Disorders of sex chromosomes: Pathology review
HIV and AIDS: Pathology review
Miscellaneous genetic disorders: Pathology review
Papulosquamous and inflammatory skin disorders: Pathology review
Anxiety disorders, phobias and stress-related disorders: Pathology Review
Developmental and learning disorders: Pathology review
Eating disorders: Pathology review
Mood disorders: Pathology review
Breastfeeding
Pharmacodynamics: Agonist, partial agonist and antagonist
Pharmacodynamics: Desensitization and tolerance
Pharmacodynamics: Drug-receptor interactions
Pharmacokinetics: Drug absorption and distribution
Pharmacokinetics: Drug elimination and clearance
Pharmacokinetics: Drug metabolism
Androgens and antiandrogens
Estrogens and antiestrogens
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Antihistamines for allergies
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Antimetabolites: Sulfonamides and trimethoprim
Antituberculosis medications
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Fluoroquinolones
DNA synthesis inhibitors: Metronidazole
Miscellaneous protein synthesis inhibitors
Protein synthesis inhibitors: Aminoglycosides
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Pulmonary corticosteroids and mast cell inhibitors
Glucocorticoids
Azoles
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants

Assessments

USMLE® Step 2 questions

0 / 4 complete

Decision-Making Tree

Questions

USMLE® Step 2 style questions USMLE

0 of 4 complete

A 19-year-old man presents to the primary care clinic due to weakness for the past few months. He has intermittent, mild achiness throughout his abdomen that tends to come and go. Past medical history is significant for delayed growth throughout childhood and recurrent kidney stones. The patient has also had two urinary tract infections in the past two years. On review of systems, he has no acute weight changes, polyuria, vomiting, or diarrhea. He does not consume tobacco, alcohol, or other recreational drugs. He does not take any medication or supplements. Vital signs are within normal limits. On physical examination, the patient seems underdeveloped in stature and muscle mass. Muscle strength is grossly 4/5 in all four extremities. Fingerstick blood glucose is 160 mg/dL. Which of the following is most likely to be seen ihis bloodwork results? 

Transcript

Watch video only

Metabolic acidosis refers to an increase in hydrogen ion concentration and a decrease in bicarbonate concentration in the blood. This can cause the pH to fall below 7.35 and serum bicarbonate level under 22 milliequivalents per liter. As a reference bicarbonates normally range from 22 to 27 miliequivalents per liter. Metabolic acidosis can be classified as either normal anion gap metabolic acidosis, which occurs in conditions like renal tubular acidosis, or elevated anion gap metabolic acidosis, which is seen in conditions like ketoacidosis.

If a patient presents with a chief concern suggesting metabolic acidosis, first perform an ABCDE assessment to determine if they are unstable.

If your patient is unstable, stabilize their airway, breathing, and circulation. Next, obtain IV access, put your patient on continuous vital sign monitoring, and provide supplemental oxygen, if needed. Here’s a clinical pearl! Severe cases might present with nausea, vomiting, lethargy, and tachypnea; and might need treatment with hemodialysis.

Let’s move on to stable patients. First, obtain a focused history and physical exam and order labs, including an arterial blood gas analysis or ABG, and CMP.

Patients may report diarrhea and vomiting, or they may have a history of diabetes mellitus. The physical exam might reveal signs of dehydration, such as dry oral mucous membranes and decreased skin turgor, and there might be an increased respiratory rate as the body tries to compensate for the acidosis.

If the ABG shows an arterial pH below 7.35 and the CMP shows decreased serum bicarbonate, typically below 22 milliequivalents per liter, that’s metabolic acidosis.

Here’s a clinical pearl! In metabolic acidosis, the body tries to compensate by increasing the rate and depth of breathing, which eliminates CO2 and lowers the pCO2.

To assess if the compensation is adequate, use the Winter formula: the range of expected pCO2 is equal to 1.5 times the bicarbonate level, plus 8, and plus or minus 2. If the measured pCO2 falls within this calculated range, the respiratory compensation is adequate. On the flip side, if the measured pCO2 is higher than calculated, there might be both metabolic and respiratory acidosis occurring at the same time.

Lastly, if the measured pCO2 is lower than calculated, your patient might be having concurrent metabolic acidosis and respiratory alkalosis.

Now that you know your patient has metabolic acidosis, your next step is to calculate the anion gap. The normal anion gap is due to the difference between unmeasured anions like sulfate, phosphate, albumin, and organic anions and cations such as potassium, magnesium, and calcium. Therefore, fluctuations in these unmeasured anions and cations may influence the anion gap. To calculate use this formula: serum sodium minus the sum of the serum chloride and bicarbonate.

Okay, let’s go over a normal anion gap range. A normal anion gap ranges from 4 to 12 milliequivalents per liter. If your patient has a normal anion gap, look for the specific cause. To remember the causes of normal anion gap metabolic acidosis, use the mnemonic HARDUPS. H stands for hyperalimentation, which is the delivery of nutrients into the vein, hypoadrenalism and hypoaldosteronism; A for acetazolamide, R for renal tubular acidosis, D for diarrhea, U for ureterostomies, P for post-hypocapnic state, and finally, S stands for spironolactone as well as saline infusion.

Okay, let’s first go over iatrogenic causes, referring to hyperalimentation, saline infusion, and acetazolamide. In such cases, patients might have a recent history of receiving total parenteral nutrition or TPN, or infusion of a large volume of IV normal saline When amino acids in TPN are metabolized, a lot of hydrogen ions are released which decreases the pH. Next, saline in large amounts can dilute the serum bicarbonate concentration and disrupt the body's acid-base balance due to excess chloride administered relative to sodium. Additionally, they might report taking medications, such as carbonic anhydrase inhibitors, like acetazolamide, or potassium-sparing diuretics, like amiloride. If this is the case, your patient’s metabolic acidosis is due to iatrogenic causes.

Moving on to renal tubular acidosis, which causes metabolic acidosis due to either impairment of hydrogen secretion like in types 1 and 4 or bicarbonate absorption like in type 2.

These patients often report muscle weakness, and possibly a history of recurrent urinary tract infections and kidney stones. Their CMP may show slightly elevated BUN and creatinine.
With these findings, consider renal tubular acidosis, and calculate the eGFR.
Normal eGFR, meaning above 60 milliliters per minute, confirms your diagnosis of renal tubular acidosis.

Next up is gastrointestinal loss of bicarbonate through diarrhea. Patients typically report profuse diarrhea, while the physical exam may show signs of dehydration, like dry mucous membranes or decreased skin turgor. Additionally, CMP reveals decreased sodium and potassium levels. If you see these findings, the patient’s metabolic acidosis is due to gastrointestinal loss of bicarbonate.

Let's go over an elevated anion gap range. Let’s start with methanol and ethylene glycol toxicity.

Alright, let’s take a step back to the anion gap, and have a look at individuals with an anion gap of more than 12 milliequivalents per liter. In this case, your patient has an elevated anion gap metabolic acidosis. To remember the causes, use a mnemonic GOLD MARK. G stands for glycols, O for oxoproline, L for L-lactate, D for D-lactate, M for methanol, A for aspirin, R for renal failure, and lastly, K stands for ketoacidosis.

Sources

  1. "Diabetic ketoacidosis: role of the kidney in the acid-base homeostasis re-evaluated." Kidney Int. (1984;25(4):591-598. )
  2. "Renal Tubular Acidosis. Indian" J Pediatr. (2020;87(9):733-744. )
  3. "Acute iron poisoning: management guidelines. " Indian Pediatr (2003;40(6):534-540. )
  4. "Stewart and beyond: new models of acid-base balance. " Kidney Int. (2003;64(3):777-787. )
  5. "Joint British Diabetes Societies for Inpatient Care. The management of diabetic ketoacidosis in adults-An updated guideline from the Joint British Diabetes Society for Inpatient Care. " Diabet Med. (2022;39(6):e14788. )
  6. "Disorders associated with an altered anion gap. " Kidney Int. (1985;27(2):472-483. )
  7. "The Diagnosis and Management of Toxic Alcohol Poisoning in the Emergency Department: A Review Article. " Adv J Emerg Med. (2019;3(3):e28. Published 2019 May 22. )
  8. "Dilution acidosis and contraction alkalosis: review of a concept. " Kidney Int. (1975;8(5):279-283. )
  9. "Metabolic Acidosis in Chronic Kidney Disease: Pathogenesis, Clinical Consequences, and Treatment. " Electrolyte Blood Press. (2021;19(2):29-37. )
  10. "Serum anion gap: its uses and limitations in clinical medicine. " Clin J Am Soc Nephrol. (2007;2(1):162-174. )
  11. "Acid-Base Basics [published correction appears in " Semin Nephrol. (2019 Sep;39(5):515].)